Bristol-Myers Squibb Co (BMY) Q1 2024 Earnings Report: A Detailed Overview
Yahoo Finance · 19 hours ago
Open | 47.39 |
High | 47.50 |
Low | 44.37 |
Mkt Cap | 90.6B |
P/E (TTM) | 11.58 |
Div & Yield | 2.40 & 4.91% |
Prev. Close | 48.86 |
52 Wk. Low | 44.37 |
52 Wk. High | 69.10 |
Related stocks
American pharmaceutical company
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 11.48B | 0.60% ▲ |
Net Income | 1.76B | 12.90% ▼ |
Diluted EPS | 1.59 | 8.90% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$4.14 | - |
Q4 2023 | $1.43 | $1.59 |
Q3 2023 | $1.61 | $1.82 |
S&P FuturesES=F | 5,122.00+39.75 (+0.78%) |
Dow FuturesYM=F | 38,362.00+74.00 (+0.19%) |
Nasdaq FuturesNQ=F | 17,758.75+191.25 (+1.09%) |
Alphabet Inc.GOOG | 157.95-1.96% |
35.11+1.77% | |
Alphabet Inc.GOOGL | 156.00-1.97% |